Enact the Patient Protection Act
HB 324, the Patient Protection Act, prohibits pharmacies from selling certain drugs known to cause severe adverse effects and establishes new safety requirements for doctors who prescribe those drugs. It directly affects prescribers (like physicians) and pharmacies by restricting the sale of high-risk medications and mandating specific safeguards before they can be prescribed or dispensed. The bill creates concrete policy changes by banning these specific drug sales and requiring prescribers to follow defined safety protocols to protect patients. The law is named the Patient Protection Act as specified in the bill's title.
Bill status
passed
3 of 5 stages cleared
Introduction
Jun 2025
Committee Review
Feb 2026
House Passage
Nov 2025
Senate Passage
Governor
Introduced Jun 3, 2025
Last action Feb 11, 2026
Maddy AI version diff · 1 comparison
What changed between versions
As Introduced
→
As Passed by the House
·
3 edits
·
Nov 19, 2025
MINOR
The bill was amended to expand its scope by explicitly including 'dangerous drugs' in the definition and clarifying that veterinarians are excluded from prescriber definitions. The House version also added cosponsors and reorganized the formatting of the bill header and section numbering. These changes clarify the bill's intent to regulate prescription drugs causing severe adverse effects while excluding veterinary prescriptions from the restrictions.
Scope change
The bill's scope was expanded to explicitly include 'dangerous drugs' in the regulatory framework, and veterinarians were explicitly excluded from the definition of 'prescriber' to clarify that veterinary prescriptions are not subject to the new restrictions.
DEFINITION
Added 'dangerous drug' to the list of defined terms and specified that veterinarians licensed under Chapter 4741 are excluded from the definition of 'prescriber'.
TECHNICAL
Added cosponsor information and reorganized the bill header formatting to reflect House passage.
REQUIREMENT
Updated language to apply restrictions to 'dangerous drugs' rather than just drugs causing severe adverse effects, clarifying the regulatory scope.
Floor votes · House Nov 20, 2025
How they voted
60–27
Passed
Total votes 87
Nov 20, 2025
D
Democratic27
100% Nay
R
Republican60
100% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
7
Key actions
2
Committee
2
Feb 11, 2026
Committee
Referred to committee
upper
Nov 25, 2025
Introduced
Introduced
upper
Nov 20, 2025
House · Passed
House Vote: pass (60-27)
house
Nov 19, 2025
Lower · Passed
Passed
lower
Jun 4, 2025
Committee
Referred to committee
lower
Jun 3, 2025
Introduced
Introduced
lower
2 primary · 0 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 324
Scope: OH
Hi! I can help you understand HB 324. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline